Aimei Health Technology Co., Ltd. (AFJKR) Cash & Equivalents (2023 - 2025)

Aimei Health Technology (AFJKR) has reported Cash & Equivalents for 3 consecutive years, with $2929.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 89.62% year-over-year to $2929.0 in Q4 2025; TTM through Dec 2025 was $2929.0, a 89.62% decrease from a year earlier, with the FY2025 full-year figure at $2929.0, down 89.62% from the prior year.
• Cash & Equivalents was $2929.0 for Q4 2025 at Aimei Health Technology, down from $250000.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $580717.0 in Q4 2023 and troughed at $2138.0 in Q2 2025.
• A 3-year average of $171794.2 and a median of $103559.0 in 2024 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 141.41% in 2025, down 98.64% in 2025.
• Over 3 years, Cash & Equivalents stood at $580717.0 in 2023, then plunged by 95.14% to $28208.0 in 2024, then sank by 89.62% to $2929.0 in 2025.
• The last three Cash & Equivalents figures came in at $2929.0 (Q4 2025), $250000.0 (Q3 2025), and $2138.0 (Q2 2025), per Business Quant data.